CLINICAL_TRIALS
trial_result
· 2014-05-12
Clinical Trial Update: Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer [Phase 2]
Summary
Phase 2 trial evaluating paclitaxel and carboplatin in persistent or recurrent stage III/IV uterine cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gynecologic Oncology Group | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2014-05-12